PON2 and lip and oral cavity carcinoma: Results obtained clearly demonstrated that PON2 expression was significantly (p = 0.001) higher (2.43-fold increase) in cisplatin-resistant compared with parental HOC621 cells (Figure 7), thus highlighting that enzyme upregulation was strictly related to CDDP resistance in oral cancer cells.